BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2696071)

  • 1. Treatment of granulomatous disorders of the nose and paranasal sinuses.
    Andrassy K; Rasmussen N
    Rhinology; 1989 Dec; 27(4):221-30. PubMed ID: 2696071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical experiences with Wegener's granulomatosis from the nephrologic viewpoint].
    Zach R; Roob JM; Horn S; Kaufmann P; Winkler HM; Holzer H; Tilz GP; Pogglitsch H
    Wien Klin Wochenschr; 1991; 103(17):528-32. PubMed ID: 1949812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of Wegener's granulomatosis with necrotizing granuloma limited to intraorbital lesions].
    Fujii T; Kuwana M; Tsuzaka K; Hama N; Ogasawara T; Akizuki M
    Ryumachi; 1992 Jun; 32(3):237-44. PubMed ID: 1523526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wegener's granulomatosis treated with sulfamethoxazole-trimethoprim. Report of a case.
    Spiera H; Lawson W; Weinrauch H
    Arch Intern Med; 1988 Sep; 148(9):2065-6. PubMed ID: 3261974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midline granuloma and Wegener's granulomatosis: clinical & therapeutic considerations.
    Schechter SL; Bole GG; Walker SE
    J Rheumatol; 1976 Sep; 3(3):241-50. PubMed ID: 789880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis].
    Tervaert JW; Stegeman CA
    Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2265-7. PubMed ID: 14655291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Wegener's granulomatosis: diagnosis and treatment].
    Vera-Lastra O; Olvera-Acevedo A; McDonal-Vera A; Pacheco-Ruelas M; Gayosso-Rivera JA
    Gac Med Mex; 2009; 145(2):121-9. PubMed ID: 19518019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-neutrophil cytoplasmic anti body (ANCA)-negative limited form of Wegener's granulomatosis; report of a case].
    Sato N; Tsubochi H; Kishimoto K; Imai T; Kaimori M
    Kyobu Geka; 2007 Jul; 60(7):591-4. PubMed ID: 17642224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Wegener's granulomatosis and microscopic polyangiitis].
    Pagnoux C
    Rev Prat; 2008 Mar; 58(5):522-32. PubMed ID: 18524109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wegener's granulomatosis--clinical analysis of 18 patients group.
    Dabrowski A; Droszcz W
    Med Sci Monit; 2000; 6(1):151-7. PubMed ID: 11208304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Infectious aspects of Wegener's granulomatosis].
    Rusterholz D; Schlegel C
    Schweiz Med Wochenschr; 2000; Suppl 125():41S-43S. PubMed ID: 11141937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of Wegener's granulomatosis. Experiences with conventional and stage-adjusted treatment in 111 patients over 24 years].
    Briedigkeit L; Ulmer M; Rheinhold-Keller E; Göbel U; Natusch R; Gross WL
    Z Gesamte Inn Med; 1993 Apr; 48(4):183-9. PubMed ID: 8488691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wegener's granulomatosis. New aspects of the disease course, immunodiagnostic procedures, and stage-adapted treatment.
    Gross WL
    Sarcoidosis; 1989 Mar; 6(1):15-29. PubMed ID: 2657920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How long should cyclophosphamide therapy of Wegener's granulomatosis continue?].
    Reinhold-Keller E
    Dtsch Med Wochenschr; 2002 Sep; 127(37):1909-10. PubMed ID: 12226791
    [No Abstract]   [Full Text] [Related]  

  • 15. Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis.
    Koldingsnes W; Nossent JC
    J Rheumatol; 2003 Jan; 30(1):80-8. PubMed ID: 12508394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis.
    Metzler C; Miehle N; Manger K; Iking-Konert C; de Groot K; Hellmich B; Gross WL; Reinhold-Keller E;
    Rheumatology (Oxford); 2007 Jul; 46(7):1087-91. PubMed ID: 17519271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations.
    Seo P; Specks U; Keogh KA
    J Rheumatol; 2008 Oct; 35(10):2017-23. PubMed ID: 18688911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
    Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
    Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulomatous disorders of the nose and paranasal sinuses.
    Fuchs HA; Tanner SB
    Curr Opin Otolaryngol Head Neck Surg; 2009 Feb; 17(1):23-7. PubMed ID: 19225301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wegener's granulomatosis: treatment failure on conventional therapy.
    Locht H; Lindström FD
    J Rheumatol; 1989 Apr; 16(4):544-6. PubMed ID: 2746596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.